Loeb and Mucci Won the PCF Science Challenge Award for Prostate Cancer Diet Study

Stacy Loeb and Lorelei Mucci recently won the PCF Science Challenge Award for a project on plant-based diet for patients with Prostate Cancer.

Stacy Loeb is a Board-certified urologist at New York University Langone Medical Center and the Manhattan Veterans Affairs Hospital, specializing in prostate cancer and men’s health. She is also Board-certified in Lifestyle Medicine.

Her research focuses on optimizing prostate cancer screening and treatment, the impact of lifestyle modifications on cancer, and the implications of online health information.

Dr. Loeb is recognized for her expertise in the use of social media in medicine and hosts the Men’s Health Show on Sirius XM. In 2021, she received the Gold Cystoscope Award from the American Urological Association for her outstanding contributions to the field shortly after completing her residency.

As a Professor of Urology and Population Health at NYU and the Manhattan VA, Dr. Loeb completed her urology residency at Johns Hopkins and earned a Master’s in Comparative Effectiveness Research at NYU. She holds grants from the National Cancer Institute and the Department of Defense for her work on prostate cancer.

With over 400 peer-reviewed publications and 10 book chapters to her name, Dr. Loeb is a leading voice in prostate cancer, men’s health, digital health, and lifestyle medicine. She frequently speaks at international conferences and courses, sharing her insights on these topics.

Lorelei Mucci is a distinguished expert in cancer epidemiology, currently leading the Cancer Epidemiology and Cancer Prevention Program within the Department of Epidemiology at the Harvard T.H. Chan School of Public Health.

Her role as Deputy Associate Director for Population Science at the Dana-Farber/Harvard Cancer Center and her leadership of Strategic Research Partnerships at the American Cancer Society further underscore her commitment to advancing cancer research and prevention efforts.

Dr. Mucci earned her doctoral degree in epidemiology from Harvard, where her academic journey began. She then honed her expertise as a postdoctoral fellow in cancer epidemiology at the prestigious Karolinska Institutet in Sweden. During her time there, she gained valuable experience in leveraging nationwide health registries to investigate cancer etiology, establishing enduring collaborations with epidemiologists in the Nordic countries that continue to influence her work.

Since joining the faculty at Harvard Chan School in 2012, Dr. Mucci has focused on integrative molecular epidemiology, employing a multidisciplinary approach to examine research questions related to cancer etiology, mortality, and survivorship.

Her research encompasses both U.S. and global cohorts, reflecting her commitment to addressing cancer on an international scale. As a co-Principal Investigator for the Health Professionals Follow-up Study and the IRONMAN study, she plays a crucial role in generating insights that inform cancer prevention strategies and enhance understanding of cancer’s impact on diverse populations.

Dr. Mucci’s work not only contributes to scientific knowledge but also aims to translate findings into actionable public health interventions.

For more posts like this, visit oncodaily.com